| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation.
|
Circulation
|
2005
|
4.17
|
|
2
|
Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes.
|
J Clin Endocrinol Metab
|
2004
|
2.93
|
|
3
|
Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance.
|
Diabetes Care
|
2009
|
2.83
|
|
4
|
Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy.
|
Stroke
|
2005
|
2.24
|
|
5
|
Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3.
|
Diabetes Care
|
2010
|
1.61
|
|
6
|
Testosterone concentrations in diabetic and nondiabetic obese men.
|
Diabetes Care
|
2010
|
1.60
|
|
7
|
Increase in intranuclear nuclear factor kappaB and decrease in inhibitor kappaB in mononuclear cells after a mixed meal: evidence for a proinflammatory effect.
|
Am J Clin Nutr
|
2004
|
1.57
|
|
8
|
Sitagliptin exerts an antinflammatory action.
|
J Clin Endocrinol Metab
|
2012
|
1.55
|
|
9
|
An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol.
|
J Clin Endocrinol Metab
|
2010
|
1.48
|
|
10
|
Acute modulation of toll-like receptors by insulin.
|
Diabetes Care
|
2008
|
1.46
|
|
11
|
Orange juice or fructose intake does not induce oxidative and inflammatory response.
|
Diabetes Care
|
2007
|
1.46
|
|
12
|
Insulin as an anti-inflammatory and antiatherogenic modulator.
|
J Am Coll Cardiol
|
2009
|
1.43
|
|
13
|
Rosiglitazone, thiazolidinediones and atherosclerosis.
|
Atherosclerosis
|
2010
|
1.41
|
|
14
|
Glucose ingestion induces an increase in intranuclear nuclear factor kappaB, a fall in cellular inhibitor kappaB, and an increase in tumor necrosis factor alpha messenger RNA by mononuclear cells in healthy human subjects.
|
Metabolism
|
2006
|
1.36
|
|
15
|
Exenatide therapy in obese patients with type 2 diabetes mellitus treated with insulin.
|
Endocr Pract
|
2007
|
1.35
|
|
16
|
A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal.
|
J Clin Endocrinol Metab
|
2011
|
1.35
|
|
17
|
Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin.
|
J Clin Endocrinol Metab
|
2004
|
1.34
|
|
18
|
Proinflammatory effects of glucose and anti-inflammatory effect of insulin: relevance to cardiovascular disease.
|
Am J Cardiol
|
2006
|
1.23
|
|
19
|
Contrasting testosterone concentrations in type 1 and type 2 diabetes.
|
Diabetes Care
|
2006
|
1.18
|
|
20
|
Insulin suppresses plasma concentration of vascular endothelial growth factor and matrix metalloproteinase-9.
|
Diabetes Care
|
2003
|
1.16
|
|
21
|
Liraglutide as additional treatment for type 1 diabetes.
|
Eur J Endocrinol
|
2011
|
1.15
|
|
22
|
Testosterone concentration in young patients with diabetes.
|
Diabetes Care
|
2008
|
1.11
|
|
23
|
Low testosterone and high C-reactive protein concentrations predict low hematocrit in type 2 diabetes.
|
Diabetes Care
|
2006
|
1.11
|
|
24
|
Insulin infusion in acute illness.
|
J Clin Invest
|
2005
|
1.10
|
|
25
|
Anti-inflammatory effects of insulin.
|
Curr Opin Clin Nutr Metab Care
|
2007
|
1.10
|
|
26
|
The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes.
|
J Clin Endocrinol Metab
|
2003
|
1.08
|
|
27
|
Low-dose rosiglitazone exerts an antiinflammatory effect with an increase in adiponectin independently of free fatty acid fall and insulin sensitization in obese type 2 diabetics.
|
J Clin Endocrinol Metab
|
2006
|
1.04
|
|
28
|
Suppressive effect of insulin infusion on chemokines and chemokine receptors.
|
Diabetes Care
|
2010
|
1.03
|
|
29
|
Endothelial dysfunction, inflammation and diabetes.
|
Rev Endocr Metab Disord
|
2004
|
1.03
|
|
30
|
Durability of effects of exenatide treatment on glycemic control, body weight, systolic blood pressure, C-reactive protein, and triglyceride concentrations.
|
Endocr Pract
|
2011
|
1.01
|
|
31
|
Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome.
|
Curr Mol Med
|
2008
|
1.00
|
|
32
|
Macronutrient intake induces oxidative and inflammatory stress: potential relevance to atherosclerosis and insulin resistance.
|
Exp Mol Med
|
2010
|
0.96
|
|
33
|
Low estradiol concentrations in men with subnormal testosterone concentrations and type 2 diabetes.
|
Diabetes Care
|
2011
|
0.93
|
|
34
|
Insulin suppresses endotoxin-induced oxidative, nitrosative, and inflammatory stress in humans.
|
Diabetes Care
|
2010
|
0.92
|
|
35
|
The effects of hypogonadism on body composition and bone mineral density in type 2 diabetic patients.
|
Diabetes Care
|
2007
|
0.91
|
|
36
|
Proinflammatory and prothrombotic effects of hypoglycemia.
|
Diabetes Care
|
2010
|
0.91
|
|
37
|
Endothelial dysfunction and hypertension in diabetes mellitus.
|
Med Clin North Am
|
2004
|
0.89
|
|
38
|
Insulin suppresses the expression of amyloid precursor protein, presenilins, and glycogen synthase kinase-3beta in peripheral blood mononuclear cells.
|
J Clin Endocrinol Metab
|
2011
|
0.88
|
|
39
|
Increase in the mediators of asthma in obesity and obesity with type 2 diabetes: reduction with weight loss.
|
Obesity (Silver Spring)
|
2013
|
0.87
|
|
40
|
Anti-inflammatory effects of insulin and the pro-inflammatory effects of glucose.
|
Semin Thorac Cardiovasc Surg
|
2006
|
0.86
|
|
41
|
Clinical use of liraglutide in type 2 diabetes and its effects on cardiovascular risk factors.
|
Endocr Pract
|
2012
|
0.84
|
|
42
|
Effect of hyperglycemia and insulin in acute coronary syndromes.
|
Am J Cardiol
|
2007
|
0.83
|
|
43
|
Thiazolidinediones-improving endothelial function and potential long-term benefits on cardiovascular disease in subjects with type 2 diabetes.
|
J Diabetes Complications
|
2008
|
0.82
|
|
44
|
Insulin infusion suppresses while glucose infusion induces Toll-like receptors and high-mobility group-B1 protein expression in mononuclear cells of type 1 diabetes patients.
|
Am J Physiol Endocrinol Metab
|
2013
|
0.82
|
|
45
|
Relationship of prostate-specific antigen to age and testosterone in men with type 2 diabetes mellitus.
|
Endocr Pract
|
2008
|
0.81
|
|
46
|
A novel view of metabolic syndrome.
|
Metab Syndr Relat Disord
|
2004
|
0.81
|
|
47
|
Acute myocardial infarction, hyperglycemia, and insulin.
|
J Am Coll Cardiol
|
2009
|
0.81
|
|
48
|
Anti-inflammatory effects of insulin and pro-inflammatory effects of glucose: relevance to the management of acute myocardial infarction and other acute coronary syndromes.
|
Rev Cardiovasc Med
|
2006
|
0.80
|
|
49
|
Hypogonadotropic hypogonadism in men with type 2 diabetes.
|
Postgrad Med
|
2009
|
0.79
|
|
50
|
Oxidative stress and inflammation in hyperglycemic crises and resolution with insulin: implications for the acute and chronic complications of hyperglycemia.
|
J Diabetes Complications
|
2012
|
0.79
|
|
51
|
Use of insulin to improve glycemic control in diabetes mellitus.
|
Cardiovasc Drugs Ther
|
2008
|
0.78
|
|
52
|
Vascular reactivity and thiazolidinediones.
|
Am J Med
|
2003
|
0.77
|
|
53
|
Insulin infusion and hypoglycemia: clinical implications and prevention.
|
Crit Care Med
|
2010
|
0.76
|
|
54
|
An inflammatory tale from 3 fatty depots.
|
J Am Coll Cardiol
|
2011
|
0.75
|
|
55
|
Glucose-insulin-potassium for suspected acute myocardial infarction.
|
JAMA
|
2012
|
0.75
|
|
56
|
Comment on: Calleja et al. insulin resistance is associated with a poor response to intravenous thrombolysis in acute ischemic stroke. Diabetes Care 2011;34:2413-2417.
|
Diabetes Care
|
2012
|
0.75
|
|
57
|
Macronutrients, advanced glycation end products, and vascular reactivity.
|
Diabetes Care
|
2007
|
0.75
|
|
58
|
Glucose-insulin-potassium therapy in patients with STEMI.
|
JAMA
|
2008
|
0.75
|
|
59
|
Associations between dietary fiber and inflammation, hepatic function, and risk of type 2 diabetes in older men: potential mechanisms for the benefits of fiber on diabetes risk: response to wannamethee et Al.
|
Diabetes Care
|
2010
|
0.75
|
|
60
|
Comment on: Rizzo et al. Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition. Diabetes Care 2012;35:2076-2082.
|
Diabetes Care
|
2013
|
0.75
|
|
61
|
ADJUNCT THERAPIES IN TYPE 1 DIABETES.
|
Endocr Pract
|
2016
|
0.75
|
|
62
|
A novel antihypertensive effect of exenatide, a GLP-1 agonist.
|
Am J Hypertens
|
2010
|
0.75
|
|
63
|
Insulin therapy and lipid overload in type 2 diabetes.
|
JAMA
|
2008
|
0.75
|
|
64
|
Exogenous insulin and hypoglycemia as prognostic factors in critically ill patients.
|
JAMA
|
2004
|
0.75
|
|
65
|
Letter by Chaudhuri et al regarding article, "Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction".
|
Circulation
|
2010
|
0.75
|
|
66
|
Hyperglycemia synergizes endotoxin-induced injury in the heart: reversal with insulin.
|
Crit Care Med
|
2009
|
0.75
|
|
67
|
Classical Anti-oxidants (Scavengers) versus Biological Anti-oxidants (Suppressors of ROS Generation): ANovel Way to Explain the Anti-oxidant Paradox.
|
Metab Syndr Relat Disord
|
2004
|
0.75
|
|
68
|
Are thiazolidinediones associated with an increased risk of heart failure and cardiovascular death?
|
Nat Clin Pract Cardiovasc Med
|
2008
|
0.75
|
|
69
|
Glycaemic control and macrovascular complications of type 2 diabetes.
|
Natl Med J India
|
2009
|
0.75
|